Correlation Between Verona Pharma and Zymeworks Common

Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Zymeworks Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Zymeworks Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verona Pharma PLC and Zymeworks Common Stock, you can compare the effects of market volatilities on Verona Pharma and Zymeworks Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Zymeworks Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Zymeworks Common.

Diversification Opportunities for Verona Pharma and Zymeworks Common

0.43

Correlation Coefficient

Verona Pharma  Zymeworks Common

Very weak diversification

The 3 months correlation between Verona and Zymeworks is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Zymeworks Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zymeworks Common Stock and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Zymeworks Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zymeworks Common Stock has no effect on the direction of Verona Pharma i.e., Verona Pharma and Zymeworks Common go up and down completely randomly.

Pair Corralation between Verona Pharma and Zymeworks Common

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.85 times more return on investment than Zymeworks Common. However, Verona Pharma PLC is 1.18 times less risky than Zymeworks Common. It trades about 0.33 of its potential returns per unit of risk. Zymeworks Common Stock is currently generating about -0.1 per unit of risk. If you would invest  5,730  in Verona Pharma PLC on December 2, 2024 and sell it today you would earn a total of  1,233  from holding Verona Pharma PLC or generate 21.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Verona Pharma PLC  vs.  Zymeworks Common Stock

Verona Pharma PLC

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Zymeworks Common Stock

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zymeworks Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Zymeworks Common is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Verona Pharma and Zymeworks Common

The main advantage of trading using opposite Verona Pharma and Zymeworks Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Zymeworks Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zymeworks Common will offset losses from the drop in Zymeworks Common's long position.

The idea behind Verona Pharma PLC and Zymeworks Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.